4.6 Review

The Different Routes to Metastasis via Hypoxia-Regulated Programs

Journal

TRENDS IN CELL BIOLOGY
Volume 28, Issue 11, Pages 941-956

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tcb.2018.06.008

Keywords

-

Categories

Funding

  1. Samuel Waxman Cancer Research Foundation Tumor Dormancy Program, NIH/NCI [CA163131, CA109182, CA218024, CA196521]
  2. Einstein's Integrated Imaging Program
  3. National Institutes of Health [CA100324, CA216248]

Ask authors/readers for more resources

Hypoxia is linked to metastasis; however, how it affects metastatic progression is not clear due to limited consensus in the literature. We posit that this lack of consensus is due to hypoxia being studied using different approaches, such as in vitro, primary tumor, or metastasis assays in an isolated manner. Here, we review the pros and cons of in vitro hypoxia assays, highlight in vivo studies that inform on physiological hypoxia, and review the evidence that primary tumor hypoxia might influence the fate of disseminated tumor cells (DTCs) in secondary organs. Our analysis suggests that consensus can be reached by using in vivo methods of study, which also allow better modeling of how hypoxia affects DTC fate and metastasis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available